Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,501,150
-
Share change
-
-1,516,605
-
Total reported value
-
$16,070,000
-
Put/Call ratio
-
694%
-
Price per share
-
$4.59
-
Number of holders
-
34
-
Value change
-
-$6,253,771
-
Number of buys
-
22
-
Number of sells
-
17
Institutional Holders of InflaRx N.V. - COM (IFRX) as of Q2 2020
As of 30 Jun 2020,
InflaRx N.V. - COM (IFRX) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,501,150 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, ORBIMED ADVISORS LLC, MORGAN STANLEY, FNY Investment Advisers, LLC, Ikarian Capital, LLC, RENAISSANCE TECHNOLOGIES LLC, GOLDMAN SACHS GROUP INC, Verition Fund Management LLC, Birchview Capital, LP, and TWO SIGMA INVESTMENTS, LP.
This page lists
34
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.